Liraglutide: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
No edit summary
Line 3: Line 3:
{{Editor Help}}
{{Editor Help}}


==Overview==
'''Liraglutide''' is a glucagon-like peptide-1 ([[GLP-1]]) analog that is being developed by [[Novo Nordisk]] for the treatment of [[type 2 diabetes]].
'''Liraglutide''' is a glucagon-like peptide-1 ([[GLP-1]]) analog that is being developed by [[Novo Nordisk]] for the treatment of [[type 2 diabetes]].


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 22:25, 6 March 2009

WikiDoc Resources for Liraglutide

Articles

Most recent articles on Liraglutide

Most cited articles on Liraglutide

Review articles on Liraglutide

Articles on Liraglutide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Liraglutide

Images of Liraglutide

Photos of Liraglutide

Podcasts & MP3s on Liraglutide

Videos on Liraglutide

Evidence Based Medicine

Cochrane Collaboration on Liraglutide

Bandolier on Liraglutide

TRIP on Liraglutide

Clinical Trials

Ongoing Trials on Liraglutide at Clinical Trials.gov

Trial results on Liraglutide

Clinical Trials on Liraglutide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Liraglutide

NICE Guidance on Liraglutide

NHS PRODIGY Guidance

FDA on Liraglutide

CDC on Liraglutide

Books

Books on Liraglutide

News

Liraglutide in the news

Be alerted to news on Liraglutide

News trends on Liraglutide

Commentary

Blogs on Liraglutide

Definitions

Definitions of Liraglutide

Patient Resources / Community

Patient resources on Liraglutide

Discussion groups on Liraglutide

Patient Handouts on Liraglutide

Directions to Hospitals Treating Liraglutide

Risk calculators and risk factors for Liraglutide

Healthcare Provider Resources

Symptoms of Liraglutide

Causes & Risk Factors for Liraglutide

Diagnostic studies for Liraglutide

Treatment of Liraglutide

Continuing Medical Education (CME)

CME Programs on Liraglutide

International

Liraglutide en Espanol

Liraglutide en Francais

Business

Liraglutide in the Marketplace

Patents on Liraglutide

Experimental / Informatics

List of terms related to Liraglutide

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Liraglutide is a glucagon-like peptide-1 (GLP-1) analog that is being developed by Novo Nordisk for the treatment of type 2 diabetes.


Template:WikiDoc Sources